[
    [
        {
            "time": "",
            "original_text": "医药生物板块涨0.46% 未名医药和双鹭药业涨停",
            "features": {
                "keywords": [
                    "医药生物",
                    "未名医药",
                    "双鹭药业",
                    "涨停"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药生物板块涨0.46% 未名医药和双鹭药业涨停",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "八大券商主题策略：“药”不能停！业绩炸裂的一季报 只是开始不是结束",
            "features": {
                "keywords": [
                    "券商",
                    "主题策略",
                    "医药",
                    "一季报",
                    "业绩增长"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "八大券商主题策略：“药”不能停！业绩炸裂的一季报 只是开始不是结束",
                "Correlation": 8,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "专题研究 | 疫苗行业：2020年重磅品种持续放量，疫苗主要生产企业业绩大幅上升，疫苗行业信用中枢上移",
            "features": {
                "keywords": [
                    "疫苗",
                    "2020年",
                    "重磅品种",
                    "放量",
                    "业绩上升",
                    "信用中枢上移"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "疫苗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "专题研究 | 疫苗行业：2020年重磅品种持续放量，疫苗主要生产企业业绩大幅上升，疫苗行业信用中枢上移",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        }
    ]
]